The drug ELPIDA® (elsulfavirine) is included in the list of vital and essential drugs. The innovative drug ELPIDA® (elsulfavirine) was developed by Viriom in partnership with F. Hoffmann -La Roche (Switzerland) with the support of the Ministry of Industry and Trade within the framework of the Federal Target Program “Development of the Pharmaceutical and Medical Industry of the Russian Federation for the Period up to 2020 and Beyond” (“Pharma 2020”).